Enliven Therapeutics Schedules September Investor Circuit
Burlingame-based Enliven Therapeutics will engage with institutional investors across three major healthcare conferences this September. The clinical-stage firm, which specializes in small molecule therapeutics, aims to showcase its precision medicine pipeline during a series of private meetings and public discussions in Boston and New York.
The schedule begins September 8 at the Wells Fargo 21st Annual Healthcare Conference in Boston, focused on one-on-one sessions. The company then moves to New York for the Baird 2026 Global Healthcare Conference on September 15, followed by the Morgan Stanley 24th Annual Global Healthcare Conference on September 16. Both New York events include fireside chats alongside private investor meetings.
Management intends to highlight the company’s ongoing discovery process, which leverages clinically validated targets to develop first-in-class or best-in-class therapies. Interested parties can access a live webcast of the Morgan Stanley presentation via the investor relations portal on the company's website. The recording will remain available for public viewing for 90 days following the event.
Comments (0)
No comments yet. Be the first!